| |
| |
|
| Insider
Information: |
Evnin Anthony B |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
256,515 |
|
|
Indirect Shares
|
17,979,070 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$641,597,242 |
|
|
| Total
Shares |
18,235,585 |
|
|
| Total
Value |
$641,597,242 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 118.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Renovis Inc |
RNVS |
Director |
2008-05-02 |
0 |
2008-05-02 |
0 |
Premium* |
|
|
OTIX GLOBAL INC |
OTIX |
Director |
2004-03-11 |
33,202 |
2004-03-11 |
0 |
Premium* |
|
|
Icagen Inc |
ICGN |
Director |
2011-09-02 |
7,910 |
2011-09-02 |
0 |
Premium* |
|
|
Coley Pharmaceutical Group, Inc. |
COLY |
Director, 10% Owner |
2005-08-15 |
0 |
2005-08-15 |
50,439 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2005-09-30 |
0 |
2005-09-30 |
24,409 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
|
2022-06-16 |
215,403 |
2014-09-30 |
0 |
Premium* |
|
|
Pharmos Corp |
PARS |
Director, 10% Owner |
2006-10-25 |
0 |
2009-05-08 |
9,665,196 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2023-01-19 |
0 |
2018-11-21 |
109 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
|
0 |
2013-09-24 |
2,496,152 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-02-14 |
0 |
2015-07-27 |
0 |
Premium* |
|
|
Cantel Medical Corp |
CMN |
Director |
2021-06-02 |
0 |
2017-01-05 |
0 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
Director |
2018-07-23 |
0 |
2019-12-13 |
5,742,765 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OTIX |
OTIX GLOBAL INC |
Director |
– • – |
2004-03-11 |
4 |
S |
$10.91 |
$3,557 |
I/I |
(326) |
0 |
|
- |
|
| RNVS |
Renovis Inc |
Director |
– • – |
2008-05-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,678) |
0 |
0 |
- |
|
| RNVS |
Renovis Inc |
Director |
– • – |
2008-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,304,060) |
0 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-02 |
4 |
D |
$6.00 |
$2,043,300 |
I/I |
(340,550) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2014-09-30 |
4 |
S |
$13.56 |
$1,525,229 |
I/I |
(112,451) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-07-27 |
4 |
AS |
$47.82 |
$10,907,594 |
I/I |
(227,354) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-02-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
34,842 |
0 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2018-11-16 |
4 |
S |
$1.82 |
$274,400 |
I/I |
(151,035) |
0 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2021-06-02 |
4 |
D |
$80.59 |
$977,718 |
D/D |
(12,132) |
0 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2023-01-19 |
4 |
D |
$15.00 |
$627,615 |
D/D |
(41,841) |
0 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2018-11-21 |
4 |
B |
$2.05 |
$223 |
I/I |
109 |
109 |
2.02 |
- |
|
| OTIX |
OTIX GLOBAL INC |
Director |
– • • |
2004-02-02 |
4/A |
A |
$0.00 |
$0 |
I/I |
137 |
137 |
|
- |
|
| OTIX |
OTIX GLOBAL INC |
Director |
– • – |
2004-02-17 |
4/A |
A |
$0.00 |
$0 |
I/I |
102 |
239 |
|
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2012-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
923 |
923 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,262 |
1,262 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2017-01-18 |
4 |
B |
$76.26 |
$152,525 |
D/D |
2,000 |
3,262 |
2.39 |
- |
|
| RNVS |
Renovis Inc |
Director |
– • – |
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,678 |
5,678 |
|
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2017-03-15 |
4 |
B |
$77.88 |
$194,691 |
D/D |
2,500 |
5,762 |
2.39 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2013-04-01 |
4 |
A |
$7.25 |
$7,497 |
D/D |
1,034 |
6,018 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
510 |
6,272 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
712 |
6,984 |
0 |
- |
|
| CMN |
Cantel Medical Corp |
Director |
– • – |
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
713 |
7,697 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-02 |
4 |
D |
$6.00 |
$77,628 |
D/D |
(12,938) |
7,910 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2013-07-01 |
4 |
A |
$2.56 |
$7,060 |
D/D |
2,758 |
8,776 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • • |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,732 |
|
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
